Journal article icon

Journal article

Effects of alteplase for acute stroke according to criteria defining the EU and US marketing authorizations: individual-patient-data meta-analysis of randomized trials

Abstract:

Background: The recommended maximum age and time window for intravenous alteplase treatment of acute ischemic stroke (AIS) each differ between Europe (EU) and United States (US).

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1177/1747493017744464

Authors


More by this author
Department:
Oxford, MSD, Nuffield Dept of Population Health, Clinical Trial Service Unit
Role:
Author
More by this author
Department:
Oxford, MSD, Nuffield Dept of Population Health, Clinical Trial Service Unit
Role:
Author
More by this author
Department:
Oxford, MSD, Nuffield Dept of Population Health, Clinical Trial Service Unit
Role:
Author
Expand authors...
More from this funder
Grant:
*Grant Number Example*
Publisher:
SAGE Publications Publisher's website
Journal:
International Journal of Stroke Journal website
Volume:
13
Issue:
2
Pages:
175-189
Publication date:
2017-11-24
Acceptance date:
2017-10-01
DOI:
EISSN:
1747-4949
ISSN:
1747-4930
Pubs id:
pubs:731600
URN:
uri:6dfe9693-b743-4616-a226-1aef55c5dd40
UUID:
uuid:6dfe9693-b743-4616-a226-1aef55c5dd40
Local pid:
pubs:731600
Paper number:
2

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP